InBody (041830.KQ) Earnings Analysis

InBody (041830.KQ) next reports earnings on 2026-08-18. Trailing P/E 15.80.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 041830.KQ next report earnings?

Next earnings date2026-08-18
Consensus EPS estimaten/a
Revenue estimate68.30B

041830.KQ earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-071,224 KRWn/an/an/a
2026-02-26480.87 KRWn/an/an/a
2025-05-08555.35 KRWn/an/an/a
2025-02-20677.4 KRWn/an/an/a
2024-11-14571 KRWn/an/an/a
2024-08-14637.24 KRWn/an/an/a

041830.KQ valuation and analyst view

Trailing P/E15.80
Trailing EPS2,968.25 KRW
Price / book2.01
Dividend yield1.22%
Market cap663.07B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is InBody (041830.KQ)'s next earnings date?

InBody is next scheduled to report on 2026-08-18 and revenue estimate of 68.30B.

Did 041830.KQ beat earnings last quarter?

Consensus estimate data was not available for 041830.KQ's 2026-05-07 report.

What is 041830.KQ's current P/E ratio and EPS?

041830.KQ trades at a trailing P/E of 15.80 on trailing EPS of 2968.2513626969967 KRW.

What do analysts rate 041830.KQ?

041830.KQ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.